186 related articles for article (PubMed ID: 38083975)
1. T-2 Toxin-Mediated β-Arrestin-1 O-GlcNAcylation Exacerbates Glomerular Podocyte Injury via Regulating Histone Acetylation.
Li T; Sun W; Zhu S; He C; Chang T; Zhang J; Chen Y
Adv Sci (Weinh); 2024 Feb; 11(7):e2307648. PubMed ID: 38083975
[TBL] [Abstract][Full Text] [Related]
2. O-linked β-N-acetylglucosamine modification of proteins is essential for foot process maturation and survival in podocytes.
Ono S; Kume S; Yasuda-Yamahara M; Yamahara K; Takeda N; Chin-Kanasaki M; Araki H; Sekine O; Yokoi H; Mukoyama M; Uzu T; Araki SI; Maegawa H
Nephrol Dial Transplant; 2017 Sep; 32(9):1477-1487. PubMed ID: 28339907
[TBL] [Abstract][Full Text] [Related]
3. Hexosamine biosynthetic pathway promotes the antiviral activity of SAMHD1 by enhancing O-GlcNAc transferase-mediated protein O-GlcNAcylation.
Hu J; Gao Q; Yang Y; Xia J; Zhang W; Chen Y; Zhou Z; Chang L; Hu Y; Zhou H; Liang L; Li X; Long Q; Wang K; Huang A; Tang N
Theranostics; 2021; 11(2):805-823. PubMed ID: 33391506
[No Abstract] [Full Text] [Related]
4. Tripterygium glycoside protects diabetic kidney disease mouse serum-induced podocyte injury by upregulating autophagy and downregulating β-arrestin-1.
Zhan H; Jin J; Liang S; Zhao L; Gong J; He Q
Histol Histopathol; 2019 Aug; 34(8):943-952. PubMed ID: 30839094
[TBL] [Abstract][Full Text] [Related]
5. Cross regulation between mTOR signaling and O-GlcNAcylation.
Very N; Steenackers A; Dubuquoy C; Vermuse J; Dubuquoy L; Lefebvre T; El Yazidi-Belkoura I
J Bioenerg Biomembr; 2018 Jun; 50(3):213-222. PubMed ID: 29524020
[TBL] [Abstract][Full Text] [Related]
6. Sirt6 deficiency exacerbates podocyte injury and proteinuria through targeting Notch signaling.
Liu M; Liang K; Zhen J; Zhou M; Wang X; Wang Z; Wei X; Zhang Y; Sun Y; Zhou Z; Su H; Zhang C; Li N; Gao C; Peng J; Yi F
Nat Commun; 2017 Sep; 8(1):413. PubMed ID: 28871079
[TBL] [Abstract][Full Text] [Related]
7. mTOR/MYC Axis Regulates O-GlcNAc Transferase Expression and O-GlcNAcylation in Breast Cancer.
Sodi VL; Khaku S; Krutilina R; Schwab LP; Vocadlo DJ; Seagroves TN; Reginato MJ
Mol Cancer Res; 2015 May; 13(5):923-33. PubMed ID: 25636967
[TBL] [Abstract][Full Text] [Related]
8. Ameliorative effects of Modified Huangqi Chifeng decoction on podocyte injury via autophagy mediated by PI3K/AKT/mTOR and AMPK/mTOR pathways.
Zhao M; Yin Y; Yang B; Chang M; Ma S; Shi X; Li Q; Li P; Zhang Y
J Ethnopharmacol; 2024 Mar; 321():117520. PubMed ID: 38042389
[TBL] [Abstract][Full Text] [Related]
9. CXCR4 induces podocyte injury and proteinuria by activating β-catenin signaling.
Mo H; Ren Q; Song D; Xu B; Zhou D; Hong X; Hou FF; Zhou L; Liu Y
Theranostics; 2022; 12(2):767-781. PubMed ID: 34976212
[No Abstract] [Full Text] [Related]
10. β-arrestin-1 drives endothelin-1-mediated podocyte activation and sustains renal injury.
Buelli S; Rosanò L; Gagliardini E; Corna D; Longaretti L; Pezzotta A; Perico L; Conti S; Rizzo P; Novelli R; Morigi M; Zoja C; Remuzzi G; Bagnato A; Benigni A
J Am Soc Nephrol; 2014 Mar; 25(3):523-33. PubMed ID: 24371298
[TBL] [Abstract][Full Text] [Related]
11. Integrated single-cell RNA-seq analysis revealed podocyte injury through activation of the BMP7/AMPK/mTOR mediated autophagy pathway.
Lin H; Chen H; Qian R; Tang G; Ding Y; Jiang Y; Chen C; Wang D; Chu M; Guo X
Chem Biol Interact; 2023 Sep; 382():110559. PubMed ID: 37247809
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of high mobility group box 1 (HMGB1) attenuates podocyte apoptosis and epithelial-mesenchymal transition by regulating autophagy flux.
Jin J; Gong J; Zhao L; Zhang H; He Q; Jiang X
J Diabetes; 2019 Oct; 11(10):826-836. PubMed ID: 30864227
[TBL] [Abstract][Full Text] [Related]
13. β-Arrestin 1/2 Aggravates Podocyte Apoptosis of Diabetic Nephropathy via Wnt/β-Catenin Pathway.
Wang Y; Li H; Song SP
Med Sci Monit; 2018 Mar; 24():1724-1732. PubMed ID: 29572435
[TBL] [Abstract][Full Text] [Related]
14. Rapamycin upregulates autophagy by inhibiting the mTOR-ULK1 pathway, resulting in reduced podocyte injury.
Wu L; Feng Z; Cui S; Hou K; Tang L; Zhou J; Cai G; Xie Y; Hong Q; Fu B; Chen X
PLoS One; 2013; 8(5):e63799. PubMed ID: 23667674
[TBL] [Abstract][Full Text] [Related]
15. Fetal Reprogramming of Nutrient Surplus Signaling, O-GlcNAcylation, and the Evolution of CKD.
Packer M
J Am Soc Nephrol; 2023 Sep; 34(9):1480-1491. PubMed ID: 37340541
[TBL] [Abstract][Full Text] [Related]
16. Histone modification in podocyte injury of diabetic nephropathy.
Wang S; Zhang X; Wang Q; Wang R
J Mol Med (Berl); 2022 Oct; 100(10):1373-1386. PubMed ID: 36040515
[TBL] [Abstract][Full Text] [Related]
17. Sevoflurane postconditioning reduces myocardial ischemia reperfusion injury-induced necroptosis by up-regulation of OGT-mediated O-GlcNAcylated RIPK3.
Zhang J; Yu P; Hua F; Hu Y; Xiao F; Liu Q; Huang D; Deng F; Wei G; Deng W; Ma J; Zhu W; Zhang J; Yu S
Aging (Albany NY); 2020 Nov; 12(24):25452-25468. PubMed ID: 33231560
[TBL] [Abstract][Full Text] [Related]
18. sPLA2-IB and PLA2R mediate insufficient autophagy and contribute to podocyte injury in idiopathic membranous nephropathy by activation of the p38MAPK/mTOR/ULK1
Yang L; Wu Y; Lin S; Dai B; Chen H; Tao X; Li G; Wan J; Pan Y
FASEB J; 2021 Feb; 35(2):e21170. PubMed ID: 33184968
[TBL] [Abstract][Full Text] [Related]
19. β-Arrestins promote podocyte injury by inhibition of autophagy in diabetic nephropathy.
Liu J; Li QX; Wang XJ; Zhang C; Duan YQ; Wang ZY; Zhang Y; Yu X; Li NJ; Sun JP; Yi F
Cell Death Dis; 2016 Apr; 7(4):e2183. PubMed ID: 27054338
[TBL] [Abstract][Full Text] [Related]
20. Moderate mammalian target of rapamycin inhibition induces autophagy in HTR8/SVneo cells via O-linked β-N-acetylglucosamine signaling.
Zhang Q; Na Q; Song W
J Obstet Gynaecol Res; 2017 Oct; 43(10):1585-1596. PubMed ID: 28691313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
